Back to HomeBeta

ICD-10 Coding for Infiltrating Ductal Carcinoma(C50.211, C50.212)

Complete ICD-10-CM coding and documentation guide for Infiltrating Ductal Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Invasive Ductal CarcinomaIDC

Related ICD-10 Code Ranges

Complete code families applicable to Infiltrating Ductal Carcinoma

C50.0-C50.9Primary Range

Malignant neoplasm of breast

This range includes all codes related to breast cancer, including specific quadrants and laterality for IDC.

Secondary malignant neoplasm of bone

Used to code for metastatic sites related to primary breast cancer.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C50.211Malignant neoplasm of upper-inner quadrant of right female breastUse when IDC is confirmed in the upper-inner quadrant of the right breast.
  • Biopsy confirming IDC
  • Imaging showing mass in specified quadrant
C50.212Malignant neoplasm of upper-inner quadrant of left female breastUse when IDC is confirmed in the upper-inner quadrant of the left breast.
  • Biopsy confirming IDC
  • Imaging showing mass in specified quadrant

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for infiltrating ductal carcinoma

Essential facts and insights about Infiltrating Ductal Carcinoma

The ICD-10 code for infiltrating ductal carcinoma varies by quadrant and laterality, such as C50.211 for the upper-inner quadrant of the right breast.

Primary ICD-10-CM Codes for infiltrating ductal carcinoma

Malignant neoplasm of upper-inner quadrant of right female breast
Billable Code

Decision Criteria

documentation Criteria

  • Quadrant and laterality must be documented.

Applicable To

  • Infiltrating ductal carcinoma of the upper-inner quadrant

Excludes

  • Benign neoplasm of breast

Clinical Validation Requirements

  • Biopsy confirming IDC
  • Imaging showing mass in specified quadrant

Code-Specific Risks

  • Incorrect laterality documentation
  • Unspecified quadrant leading to incorrect coding

Coding Notes

  • Ensure documentation specifies both quadrant and laterality to avoid unspecified codes.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Secondary malignant neoplasm of bone

C79.51
Use when there is documented metastasis to bone from IDC.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of unspecified site of right female breast

C50.911
Use C50.911 only when the specific quadrant is not documented.

Malignant neoplasm of unspecified site of left female breast

C50.912
Use C50.912 only when the specific quadrant is not documented.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Infiltrating Ductal Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C50.211.

Impact

Clinical: May affect treatment decisions and outcomes., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials or reduced reimbursement.

Mitigation Strategy

Ensure receptor status is included in pathology reports, Train staff on importance of complete documentation

Impact

Reimbursement: Potential for reduced reimbursement due to lack of specificity., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Decreased accuracy in clinical data reporting.

Mitigation Strategy

Always code to the highest level of specificity available in the documentation.

Impact

High risk of audit if unspecified codes are used when specific documentation is available.

Mitigation Strategy

Implement regular documentation audits to ensure specificity.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Infiltrating Ductal Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Infiltrating Ductal Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Infiltrating Ductal Carcinoma. These templates include all required elements for proper coding and billing.

Pathology report for IDC

Specialty: Oncology

Required Elements

  • Histologic type
  • Tumor size
  • Grade
  • Margins
  • Receptor status

Example Documentation

Infiltrating ductal carcinoma, 2.1 cm, grade 2, ER+/PR+, HER2-negative, margins clear.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Breast cancer, left side.
Good Documentation Example
Infiltrating ductal carcinoma, 1.8 cm, upper inner quadrant of left breast, Nottingham grade 2, ER 95%, PR 30%, HER2-negative.
Explanation
The good example provides specific details on location, size, grade, and receptor status, which are necessary for accurate coding.

Need help with ICD-10 coding for Infiltrating Ductal Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more